tiprankstipranks
Trending News
More News >

Omada Health initiated with a Buy at Goldman Sachs

Goldman Sachs analyst David Roman initiated coverage of Omada Health (OMDA) with a Buy rating and $29 price target Considering the growth trajectory, near-term path to profitability, and below peer valuation, the analyst sees shares offering a “compelling risk/reward” at current levels, the analyst tells investors.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1